261 related articles for article (PubMed ID: 27222938)
1. Metformin, other antidiabetic drugs, and endometrial cancer risk: a nested case-control study within Italian healthcare utilization databases.
Franchi M; Asciutto R; Nicotra F; Merlino L; La Vecchia C; Corrao G; Bosetti C
Eur J Cancer Prev; 2017 May; 26(3):225-231. PubMed ID: 27222938
[TBL] [Abstract][Full Text] [Related]
2. Insulin and other antidiabetic drugs and hepatocellular carcinoma risk: a nested case-control study based on Italian healthcare utilization databases.
Bosetti C; Franchi M; Nicotra F; Asciutto R; Merlino L; La Vecchia C; Corrao G
Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):771-8. PubMed ID: 26013675
[TBL] [Abstract][Full Text] [Related]
3. Metformin and the risk of endometrial cancer: a case-control analysis.
Becker C; Jick SS; Meier CR; Bodmer M
Gynecol Oncol; 2013 Jun; 129(3):565-9. PubMed ID: 23523618
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
[TBL] [Abstract][Full Text] [Related]
5. Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case-control study.
Wang MT; Lai JH; Huang YL; Kuo FC; Wang YH; Tsai CL; Tu MY
Respir Res; 2020 Dec; 21(1):319. PubMed ID: 33267895
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
[TBL] [Abstract][Full Text] [Related]
7. Diabetic Pharmacotherapy and Endometrial Cancer Risk Within a Publicly Funded Health Care System.
Kwon JS; Albert AY; Gill S; Hutcheon JA
J Obstet Gynaecol Can; 2017 Jan; 39(1):42-48. PubMed ID: 28062022
[TBL] [Abstract][Full Text] [Related]
8. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
9. Metformin and the risk of renal cell carcinoma: a case-control analysis.
Becker C; Jick SS; Meier CR; Bodmer M
Eur J Cancer Prev; 2017 May; 26(3):257-262. PubMed ID: 26945286
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.
Azoulay L; Schneider-Lindner V; Dell'aniello S; Schiffrin A; Suissa S
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):335-42. PubMed ID: 20052677
[TBL] [Abstract][Full Text] [Related]
11. Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database.
Soranna D; Bosetti C; Casula M; Tragni E; Catapano AL; Vecchia CL; Merlino L; Corrao G
Diabetes Res Clin Pract; 2015 May; 108(2):243-9. PubMed ID: 25748827
[TBL] [Abstract][Full Text] [Related]
12. Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication.
Koro CE; Bowlin SJ; Weiss SR
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):697-703. PubMed ID: 15654719
[TBL] [Abstract][Full Text] [Related]
13. No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study.
Becker C; Jick SS; Meier CR; Bodmer M
BMC Cancer; 2015 Oct; 15():719. PubMed ID: 26475035
[TBL] [Abstract][Full Text] [Related]
14. Antidiabetic Medications and the Risk of Endometrial Cancer in Patients.
Tian J; Liang Y; Qu P
Gynecol Obstet Invest; 2019; 84(5):455-462. PubMed ID: 30808843
[TBL] [Abstract][Full Text] [Related]
15. Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis.
Bodmer M; Becker C; Meier C; Jick SS; Meier CR
Am J Gastroenterol; 2012 Apr; 107(4):620-6. PubMed ID: 22290402
[TBL] [Abstract][Full Text] [Related]
16. Insulin use increases risk of asthma but metformin use reduces the risk in patients with diabetes in a Taiwanese population cohort.
Chen CZ; Hsu CH; Li CY; Hsiue TR
J Asthma; 2017 Dec; 54(10):1019-1025. PubMed ID: 28135899
[TBL] [Abstract][Full Text] [Related]
17. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
[TBL] [Abstract][Full Text] [Related]
18. Metformin use and prostate cancer risk.
Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
[TBL] [Abstract][Full Text] [Related]
19. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
Simeone JC; Quilliam BJ
Ann Pharmacother; 2012 Feb; 46(2):157-68. PubMed ID: 22234990
[TBL] [Abstract][Full Text] [Related]
20. Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study.
Imfeld P; Bodmer M; Jick SS; Meier CR
J Am Geriatr Soc; 2012 May; 60(5):916-21. PubMed ID: 22458300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
